Nature Communications (Feb 2023)

Splicing factor SRSF1 deficiency in the liver triggers NASH-like pathology and cell death

  • Waqar Arif,
  • Bhoomika Mathur,
  • Michael F. Saikali,
  • Ullas V. Chembazhi,
  • Katelyn Toohill,
  • You Jin Song,
  • Qinyu Hao,
  • Saman Karimi,
  • Steven M. Blue,
  • Brian A. Yee,
  • Eric L. Van Nostrand,
  • Sushant Bangru,
  • Grace Guzman,
  • Gene W. Yeo,
  • Kannanganattu V. Prasanth,
  • Sayeepriyadarshini Anakk,
  • Carolyn L. Cummins,
  • Auinash Kalsotra

DOI
https://doi.org/10.1038/s41467-023-35932-3
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 19

Abstract

Read online

Nonalcoholic steatohepatitis (NASH) is an advanced form of fatty liver disease with complex pathogenic mechanisms. Here, the authors report that SRSF1 deficiency in mice livers provokes deleterious R-loop formation and genotoxicity, which impedes hepatocellular gene expression, metabolism, and lipid trafficking, resulting in NASH-like pathology.